Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

VE-821

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

EMD Serono, Vertex

Drug class:

ATR inhibitor

Related drugs:

ARID1A 756fs	Ovarian Cancer	ARID1A 756fs	Ovarian Cancer	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D
ARID1A 548fs	Ovarian Cancer	ARID1A 548fs	Ovarian Cancer	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D
TP53 mutation	Multiple Myeloma	TP53 mutation	Multiple Myeloma	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D
TP53 mutation	Multiple Myeloma	TP53 mutation	Multiple Myeloma	CX-5461 + VE-821 Sensitive: D – Preclinical CX-5461 + VE-821 Sensitive : D	CX-5461 + VE-821 Sensitive: D – Preclinical CX-5461 + VE-821 Sensitive : D
ATM deletion	Lung Adenocarcinoma	ATM deletion	Lung Adenocarcinoma	olaparib + VE-821 Sensitive: D – Preclinical olaparib + VE-821 Sensitive : D	olaparib + VE-821 Sensitive: D – Preclinical olaparib + VE-821 Sensitive : D
SF3B1 mutation	Chronic Myeloid Leukemia	SF3B1 mutation	Chronic Myeloid Leukemia	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D